FDA Seeks Input On Reporting Race, Ethnicity In Drug Trials
The Food and Drug Administration asked the healthcare industry Monday for comment on updated guidance that outlines the agency's expectations for collecting race and ethnicity data in drug and medical device...To view the full article, register now.
Already a subscriber? Click here to view full article